126 related articles for article (PubMed ID: 6440788)
1. Dose-dependent change in tissue uptake of 17 beta-(16 alpha-[125I]iodo)-estradiol in female rats: application to external imaging of mammary carcinoma.
Noguchi S; Koyama H; Nakano S
Eur J Nucl Med; 1984; 9(11):490-3. PubMed ID: 6440788
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors.
Mathias CJ; Welch MJ; Katzenellenbogen JA; Brodack JW; Kilbourn MR; Carlson KE; Kiesewetter DO
Int J Rad Appl Instrum B; 1987; 14(1):15-25. PubMed ID: 3108199
[TBL] [Abstract][Full Text] [Related]
3. Radioiodinated ligands for the estrogen receptor: tissue distribution of 17 alpha-[125I]iodovinylestradiol derivatives in normal and tumor-bearing adult female rats.
Hanson RN; Franke LA; Kaplan M
Int J Rad Appl Instrum B; 1990; 17(2):239-45. PubMed ID: 2111297
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and breast tumor uptake of 16alpha-[18F]-fluoro-17beta-estradiol in rat.
Sasaki M; Fukumura T; Kuwabara Y; Yoshida T; Nakagawa M; Ichiya Y; Masuda K
Ann Nucl Med; 2000 Apr; 14(2):127-30. PubMed ID: 10830531
[TBL] [Abstract][Full Text] [Related]
6. Studies with 17 beta(16 alpha-[125i]iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors.
Gatley SJ; Shaughnessy WJ; Inhorn L; Leiberman LM
J Nucl Med; 1981 May; 22(5):459-64. PubMed ID: 7218023
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats.
Feenstra A; Vaalburg W; Nolten GM; Reiffers S; Talma AG; Wiegman T; van der Molen HD; Woldring MG
J Nucl Med; 1983 Jun; 24(6):522-8. PubMed ID: 6406650
[TBL] [Abstract][Full Text] [Related]
8. Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs.
Katzenellenbogen JA; Carlson KE; Heiman DF; Goswami R
J Nucl Med; 1980 Jun; 21(6):550-8. PubMed ID: 6247466
[TBL] [Abstract][Full Text] [Related]
9. New iodinated progestins as potential ligands for progesterone receptor imaging in breast cancer. Part 2: In vivo pharmacological characterization.
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Janssen AG; van Royen EA
Nucl Med Biol; 1998 Nov; 25(8):791-8. PubMed ID: 9863568
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacokinetics of 131I labeled benzoyl derivatives of estrone and estradiol.
Brandau W; Eisenhut M; Taylor DM
Int J Appl Radiat Isot; 1985 May; 36(5):379-84. PubMed ID: 3926658
[TBL] [Abstract][Full Text] [Related]
11. 16 alpha-[77Br]bromoestradiol-17 beta: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and uterus and induced mammary tumors.
Katzenellenbogen JA; Senderoff SG; McElvany KD; O'Brien HA; Welch MJ
J Nucl Med; 1981 Jan; 22(1):42-7. PubMed ID: 6778976
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Doornbos T; Vekemans JA; Posthumus MA; Janssen AG; van Royen EA
Nucl Med Biol; 1998 May; 25(4):411-21. PubMed ID: 9639304
[TBL] [Abstract][Full Text] [Related]
13. Mammary tumor immunoscintigraphy in rats: the use of 131I-anti-estriol 3-sulfate antibody.
Shimura N; Komori Y; Tanaka T; Kubodera A; Oyamada H
Int J Rad Appl Instrum B; 1990; 17(6):553-60. PubMed ID: 2123840
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of 11 beta-methoxy-[16 alpha-123I] iodoestradiol and its interaction with the estrogen receptor in vivo and in vitro.
Zielinski JE; Larner JM; Hoffer PB; Hochberg RB
J Nucl Med; 1989 Feb; 30(2):209-15. PubMed ID: 2738649
[TBL] [Abstract][Full Text] [Related]
15. Biologic activity of the iodoestrogens and their use in breast cancer.
Longcope C; Arunachalam T; Rafkind I; Caspi E
Adv Exp Med Biol; 1981; 138():191-210. PubMed ID: 7342716
[TBL] [Abstract][Full Text] [Related]
16. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
[TBL] [Abstract][Full Text] [Related]
17. Organ distribution and autoradiography after administration of 125I-16 alpha-iodo-estradiol in female rats.
Holan J; Hutka Z; Stranská M; Palencárová M; Belej K; Misíková R; Levcík A; Altmann P; Putz Z
Endocrinol Exp; 1985 Dec; 19(4):297-303. PubMed ID: 3878781
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
19. 17 alpha-Z-[125I]iodovinyloestradiol and its 3-acetate: chemical synthesis in vivo distribution studies in the rat. Comparison of tissue accumulation and metabolic stability with 17 alpha-E-[125I]iodovinyl and 16 alpha-[125I]iodo oestradiols.
Symes EK; Bishop PB; Coulson WF; Davies AG
Biochem Pharmacol; 1992 Aug; 44(4):741-6. PubMed ID: 1510721
[TBL] [Abstract][Full Text] [Related]
20. 16 Alpha-[125I]iodo-11 beta-methoxy-17 beta-estradiol: a radiochemical probe for estrogen-sensitive tissues.
Zielinski JE; Yabuki H; Pahuja SL; Larner JM; Hochberg RB
Endocrinology; 1986 Jul; 119(1):130-9. PubMed ID: 3720661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
